» Articles » PMID: 30225809

Pulmonary Arterial Compliance is a Useful Predictor of Pulmonary Vascular Disease in Congenital Heart Disease

Overview
Journal Heart Vessels
Date 2018 Sep 19
PMID 30225809
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Histopathological assessment of the pulmonary arteries is crucial to determine the surgical indications in patients with congenital heart disease (CHD) and intractable pulmonary vascular disease (PVD). We aimed to clarify whether pulmonary hemodynamic parameters can predict PVD in patients with CHD and pulmonary arterial hypertension (PAH) We performed histopathological evaluations of lung specimens and cardiac catheterizations in 27 patients with CHD-PAH. We divided these patients into the patients with and without PVD, and compared pulmonary hemodynamic parameters including pulmonary arterial compliance (Cp) between two groups. Age at lung biopsy was 4 (2-7) months. There were 16 patients with trisomy 21. Cardiac diagnosis included ventricular septal defect in 16, atrial septal defect in 5, atrioventricular septal defect in 4, and others in 2. There were 11 patients with histopathologically proven PVD (Heath-Edwards classification grade ≥ 3 in 5; the index of PVD ≥ 1.1 in 3; extremely thickened media in 6; hypoplasia of the pulmonary arteries in 3). Cp in the patients with PVD was significantly lower than that in patients without PVD (0.99 [0.74-1.42] vs 1.56 [1.45-1.88], p = 0.0047), although there was no significant difference in the ratio of systemic to pulmonary blood flow, pulmonary arterial pressure, and resistance between two groups. A Cp cutoff value of < 1.22 ml/mmHg m as a predictor of PVD yielded a sensitivity and a specificity of 93% and 64%, respectively. Pulmonary arterial compliance can be a predictor of PVD among patients with CHD-PAH.

Citing Articles

Impact of Age and of the Patent Ductus Arteriosus on Pulmonary Hemodynamics in Children with Complete Atrioventricular Septal Defect.

Rocha L, Miyague N, Solarewicz L, Fernandes-Silva M Pediatr Cardiol. 2024; .

PMID: 39223337 DOI: 10.1007/s00246-024-03636-0.


Noninvasive Monitoring of Severe Pulmonary Artery Hypertension in Atrial Septal Defect Patients: Role of Serum Bilirubin Combined with Uric Acid.

Zhang F, Lin D, Jin Q, Fan J, Chen D, Guan L Rev Cardiovasc Med. 2024; 25(2):50.

PMID: 39077349 PMC: 11263178. DOI: 10.31083/j.rcm2502050.


Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study.

El-Chouli M, Meddis A, Christensen D, Gerds T, Sehested T, Malmborg M Eur Heart J. 2022; 44(9):741-748.

PMID: 36477305 PMC: 9976987. DOI: 10.1093/eurheartj/ehac727.


Comprehensive assessments of pulmonary circulation in children with pulmonary hypertension associated with congenital heart disease.

Muneuchi J, Ezaki H, Sugitani Y, Watanabe M Front Pediatr. 2022; 10:1011631.

PMID: 36313863 PMC: 9614099. DOI: 10.3389/fped.2022.1011631.


ISL1 loss-of-function mutation contributes to congenital heart defects.

Ma L, Wang J, Li L, Qiao Q, Di R, Li X Heart Vessels. 2018; 34(4):658-668.

PMID: 30390123 DOI: 10.1007/s00380-018-1289-z.

References
1.
Maeda K, Yamaki S, Yokota M, Murakami A, Takamoto S . Hypoplasia of the small pulmonary arteries in total anomalous pulmonary venous connection with obstructed pulmonary venous drainage. J Thorac Cardiovasc Surg. 2004; 127(2):448-56. DOI: 10.1016/s0022-5223(03)01193-0. View

2.
Maeda K, Yamaki S, Kado H, Asou T, Murakami A, Takamoto S . Hypoplasia of the small pulmonary arteries in hypoplastic left heart syndrome with restrictive atrial septal defect. Circulation. 2004; 110(11 Suppl 1):II139-46. DOI: 10.1161/01.CIR.0000138223.74524.4e. View

3.
Mahapatra S, Nishimura R, Sorajja P, Cha S, McGoon M . Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol. 2006; 47(4):799-803. DOI: 10.1016/j.jacc.2005.09.054. View

4.
Lankhaar J, Westerhof N, Faes T, Marques K, Marcus J, Postmus P . Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2006; 291(4):H1731-7. DOI: 10.1152/ajpheart.00336.2006. View

5.
Lankhaar J, Westerhof N, Faes T, Gan C, Marques K, Boonstra A . Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J. 2008; 29(13):1688-95. DOI: 10.1093/eurheartj/ehn103. View